Question 1

Can we mention botulinum toxin anywhere on our website at all?

Accepted Answer

Not on anything the public can reach. UK law prohibits advertising prescription-only medicines to the public, and the ASA applies that to the whole of your public-facing estate, not merely to paid media. That covers page copy, headings, page titles and meta descriptions, URL slugs, image alt text, blog articles, social captions, Google Business Profile posts and video descriptions. Brand names and generic descriptions of the medicine are treated the same way, and a disclaimer stating the page is for information does not rescue it. Bidding on the term as a keyword raises a distinct question from publishing it as copy, and clinics regularly conflate the two. Where the rules relax is inside a genuine one-to-one consultation, where a prescriber may discuss named products with a patient properly, because that is clinical dialogue rather than advertising. That distinction is the whole strategy: everything public sells the consultation, and the consultation is where the medicine gets named. Practically, that means your treatment page is a wrinkle-treatment or facial-lines consultation page, your ads point at consultation intent, your prescribers and their registration are named prominently, and your aftercare and complications policy is published in full. Clinics find this frustrating until they see the enquiry quality, which is usually better, because you are attracting people who want a clinical assessment rather than the cheapest unit price in the postcode.

Question 2

If we cannot name the product, how do patients find us for it?

Accepted Answer

Through the channels the prohibition does not reach, and by accepting that the branded demand converts differently here than elsewhere. Three routes carry most of it. Google Business Profile and Maps are the first: patients searching the product name locally see profiles, reviews and photographs, and a fully built profile with strong review velocity captures a meaningful share of that traffic without you having written the word anywhere. Second, organic content that answers the questions surrounding the treatment — how a prescriber decides whether someone is suitable, what a first appointment involves, how long results last, what happens when something goes wrong, how to assess a practitioner's qualifications. That material genuinely ranks, because most clinics have published nothing beyond a price list, and it is increasingly the sort of content quoted back to patients by AI summaries. Third, reputation and word of mouth, which in British aesthetics carries more weight than in almost any comparable market precisely because advertising is so constrained. Patients arrive having been recommended and are looking to verify, not to discover. The strategic implication is that budget shifts from acquisition advertising toward review generation, prescriber visibility and editorial depth. It is slower to build and considerably harder for a competitor to displace once built, which is why the clinics that commit to it tend to hold their position for years.

Question 3

How much private demand do NHS dermatology waits actually create?

Accepted Answer

Enough that medical dermatology is often the more reliable half of a UK skin clinic's business, and it is routinely neglected in favour of the aesthetic half. Waits for a routine NHS dermatology appointment run to many months in a lot of areas, and the referral itself requires getting a GP appointment first. That produces a specific and quite motivated patient: someone with a mole that has changed, acne that is affecting their work, eczema or rosacea that has not responded to what a GP could prescribe, or a family history that has made them anxious. They are not shopping for a look. They want to be seen by a dermatologist soon, and they want to know what it costs and whether they need a referral to book. Those two questions decide most of these enquiries. Clinics lose them by burying medical dermatology beneath aesthetics on the site, by omitting price, and by staying silent on referral requirements and appointment timing. The fix is straightforward: dedicated pages for mole checks and skin cancer screening, acne, eczema, rosacea and psoriasis; an indicative consultation fee with what it includes; a clear statement that self-referral is accepted where it is; and a realistic time to first appointment. Advertising rules are far gentler here than on the aesthetic side, because you are not touching prescription-only medicines in public — which makes this the part of the funnel you can actually buy traffic for.

Question 4

What does dermatology & aesthetics marketing cost in the UK?

Accepted Answer

We quote clients in the UK in GBP. Google Business Profile management starts around GBP 50 per month and full-service retainers from about GBP 210 per month, scoped to how competitive your specialty and catchment are. Dermatology & Aesthetics is among the more contested categories in this market, so expect scope at the higher end where you are competing in a major city. Those figures are converted from our India list at an indicative rate and confirmed in writing after the free audit. Paid media sits outside our fee — in the UK treatment-intent clicks typically run £3–15.

Question 5

How quickly do dermatology & aesthetics clinics see results in the UK?

Accepted Answer

Profile views, calls and direction requests usually move within 30 days, because the first wins come from fixing what is already indexed. Ranking and pipeline change typically lands between 60 and 90 days. Dermatology & Aesthetics has a longer consideration window than routine care — patients research, compare and often revisit over weeks — so the enquiry that arrives in month two frequently started in month one. We report against booked consultations rather than impressions for exactly that reason, and we sequence work so there is early traction on winnable searches while the contested head terms build.

Dermatology & Aesthetics marketing in the UK

Why this market behaves differently.

How they actually choose a clinic in the UK.

Private trigger

Branded search you cannot buy

Prescriber scrutiny

Consultation as the conversion

The plays that work for this specialty in the UK.

Non-branded consultation funnels

Prescriber-led authority content

Organic and Maps capture

Medical dermatology self-pay pages

What the rules mean for dermatology & aesthetics.